BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37635316)

  • 1. Development of Enzymatic Recombinase Amplification Assays for the Rapid Visual Detection of HPV16/18.
    Ding N; Qi W; Wu Z; Zhang Y; Xu R; Lin Q; Zhu J; Zhang H
    J Microbiol Biotechnol; 2023 Aug; 33(8):1091-1100. PubMed ID: 37635316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
    Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
    Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent.
    Wang J; Liu J; Song G; Cao Z; Pan J; Li X; Gao Y; Qi J; Chen Z; Fan G; Bai X; Zhang R; Wang R; Duan Q; Li L; Shen X; Ma X
    Arch Virol; 2020 Oct; 165(10):2241-2247. PubMed ID: 32681408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA.
    Ying J; Mao L; Tang Y; Fassatoui M; Song W; Xu X; Tang X; Li J; Liu H; Jian F; Du Q; Wong G; Feng W; Berthet N
    Microbiol Spectr; 2023 Dec; 11(6):e0120723. PubMed ID: 37787547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection assay for HPV16 and HPV18 by loop‑mediated isothermal amplification with lateral flow dipstick tests.
    Kumvongpin R; Jearanaikoon P; Wilailuckana C; Sae-Ung N; Prasongdee P; Daduang S; Wongsena M; Boonsiri P; Kiatpathomchai W; Swangvaree SS; Sandee A; Daduang J
    Mol Med Rep; 2017 May; 15(5):3203-3209. PubMed ID: 28339040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitivity, loop-mediated isothermal amplification combined with colorimetric gold-nanoparticle probes for visual detection of high risk human papillomavirus genotypes 16 and 18.
    Kumvongpin R; Jearanaikool P; Wilailuckana C; Sae-Ung N; Prasongdee P; Daduang S; Wongsena M; Boonsiri P; Kiatpathomchai W; Swangvaree SS; Sandee A; Daduang J
    J Virol Methods; 2016 Aug; 234():90-5. PubMed ID: 27086727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA.
    Daskou M; Tsakogiannis D; Dimitriou TG; Amoutzias GD; Mossialos D; Kottaridi C; Gartzonika C; Markoulatos P
    J Virol Methods; 2019 Aug; 270():87-94. PubMed ID: 31042552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening.
    Zhao Y; Cao X; Tang J; Zhou L; Gao Y; Wang J; Zheng Y; Yin S; Wang Y
    Mol Cell Probes; 2012 Apr; 26(2):66-72. PubMed ID: 22293505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
    PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower cost strategies for triage of human papillomavirus DNA-positive women.
    Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of HPV16/18 based on a CRISPR-Cas13a/Cas12a dual-channel system.
    Zheng X; Li Y; Yuan M; Shen Y; Chen S; Duan G
    Anal Methods; 2022 Dec; 14(48):5065-5075. PubMed ID: 36449008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
    Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
    Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
    Xiao H; Chen W; Lin M; Jiang S; Cui X; Zhao S
    Anal Methods; 2024 Mar; 16(13):1862-1869. PubMed ID: 38463013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker.
    Rungkamoltip P; Temisak S; Piboonprai K; Japrung D; Thangsunan P; Chanpanitkitchot S; Chaowawanit W; Chandeying N; Tangjitgamol S; Iempridee T
    Exp Biol Med (Maywood); 2021 Mar; 246(6):654-666. PubMed ID: 33307803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.